Présentation
Nicolas GUEGAN
Après une licence professionnelle en biotechnologies faite en alternance à Sanofi-Aventis, Nicolas a été recruté en 2009 comme Assistant Ingénieur dans le laboratoire d’immunité intestinale.
Son travail au sein du laboratoire s’intègre dans un axe principal de recherche visant à élucider la physiopathologie des complications de la maladie cœliaque.
Ressources & publications
-
2019Journal (source)Hum. Mol. Genet.Human IFT52 mutations uncover a novel role for the protein in microtubule dyn...
-
2018Journal (source)Am. J. Hum. Genet.
Mutations in TUBB4B Cause a Distinctive Sensorineural Disease.
-
2018Journal (source)Hum. Mol. Genet.
Constitutively-active FGFR3 disrupts primary cilium length and IFT20 traffick...
-
2015Journal (source)Am J Hum Genet
Mutations in KIAA0586 Cause Lethal Ciliopathies Ranging from a Hydrolethalus ...
-
2015Journal (source)J Med Genet
IFT81, encoding an IFT-B core protein, as a very rare cause of a ciliopathy p...
-
2017Journal (source)Am J Hum Genet
Mutations in TUBB4B Cause a Distinctive Sensorineural Disease.
-
2017Journal (source)Am J Hum Genet
Mutations in TUBB4B Cause a Distinctive Sensorineural Disease.
-
Journal (source)Proc Natl Acad Sci U S A
Agonists of prostaglandin E2 receptors as potential first in class treatment ...
-
2017Journal (source)Am J Hum Genet
Mutations in TUBB4B Cause a Distinctive Sensorineural Disease.
-
2015Journal (source)J Med Genet
IFT81, encoding an IFT-B core protein, as a very rare cause of a ciliopathy p...